ECDC

TB molecular surveillance status report, focussing on rifampicin and multidrug resistance in the EU/EEA

The European Centre for Disease Prevention and Control (ECDC) released a report providing an overview of the dynamics and geographical distribution of rifampicin-resistant (RR)- and multidrug-resistant (MDR) Mycobacterium tuberculosis strains in the European Union/European Economic Area (EU/EEA), focussing on the strains isolated in 2020−2022, and comparing this with whole genome sequencing data collected in 2017−2019 as a part of an EU/EEA pilot project on TB molecular surveillance.

Read More →

ECDC: Tuberculosis - Annual epidemiological report for 2021

For 2021, the 30 countries in the European Union/European Economic Area (EU/EEA) reported a total of 33 527 tuberculosis (TB) cases (7.4 per 100 000 population).

Read More →

Unfinished business: The challenge of ending TB in the European Region

On World TB Day 2023, ECDC and WHO/Europe issue a sobering warning that, despite having the tools to end TB, the European Region remains a long way from meeting its End TB Strategy targets.

Read More →

ECDC-WHO/Europe World TB Day webinar

The European Centre for Disease Prevention and Control (ECDC) and the World Health Organization Regional Office for Europe (WHO/Europe) will host a webinar on 22 March 2023 to mark World TB Day, 'Measuring progress, moving forward towards Ending TB in Europe and Central Asia'.

Read More →

Testing for TB infection and screening for TB disease among incoming refugees from Ukraine to European countries

7 Apr 2022: In the context of the mass influx of refugees from Ukraine into the European Union (EU), the European Economic Area (EEA) and other European countries, ECDC and the WHO Regional Office for Europe are releasing today an information note on testing for tuberculosis infection and screening for tuberculosis disease.

Read More →

ECDC-WHO report: TB surveillance and monitoring in Europe 2020

ECDC and WHO/Europe release a joint report providing an overview of the latest TB epidemiological situation in the WHO European Region.

Read More →

Ending TB is a race against time and drug resistance

TB burden in the WHO European Region as a whole is decreasing. However, TB is second only to COVID-19 as an infectious disease that kills, and drug resistance is a major concern.

Read More →

ECDC: Tuberculosis - Annual epidemiological report for 2018

For 2018, 30 countries in the European Union/European Economic Area (EU/EEA) reported a total of 52 862 tuberculosis (TB) cases (10.2 per 100 000 population).

Read More →

Despite 4% decline in EU/EEA TB cases, challenges remain in achieving targets

A joint ECDC – WHO report released on 24 March 2020 shows an overall decline of 4% in the number of notified tuberculosis cases between 2014 and 2018 in the EU/EEA countries. Although this is evidence of improvement, the treatment success rates for new and relapse cases, as well as for patients with drug-resistant TB are still below regional and global targets. Improvements can be achieved through, for example, better management of latent TB as a preventative measure against active TB, says ECDC.

Read More →

TB in the Netherlands

The European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) released a joint report reviewing the TB prevention and care system in the Netherlands.

Read More →

Page 1 of 5 · Total posts: 10

1 2 Last→